With new up­date in hand, In­tel­lia CEO now claims one-time HAE gene edit­ing treat­ment 'may be a func­tion­al cure'

In Sep­tem­ber, In­tel­lia gave a first look in­to its one-time treat­ment for hered­i­tary an­gioede­ma — a dis­ease that caus­es se­vere swelling at­tacks — that di­rect­ly ed­its the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER